BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria

Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...

July 04, 2024 | News

HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...

July 02, 2024 | News

Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer

Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strength...

June 28, 2024 | News

Ochre Bio and GSK Enter Multi-Year Partnership to Advance Liver Disease Research

Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...

June 13, 2024 | News

Philips Survey Reveals Strong Public Support for Sustainable Healthcare in Asia Pacific

Royal Philips , a global leader in health technology, announced findings from its Sustainable Healthcare survey in Asia Pacific (APAC)...

June 06, 2024 | News

Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials

Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...

May 31, 2024 | News

Thermo Fisher's Mission: A Healthier, Cleaner, and Safer World, says CEO Marc N. Casper

Report highlights company’s commitments to all of its stakeholders and society Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in servin...

May 28, 2024 | Opinion

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

May 22, 2024 | News

CEO Matt Foehr Announces OmniAb's Strong Start in 2024 with New Partnerships and Expanded Portfolio

OmniAb, reported financial results for the three months ended March 31, 2024, and provided operating and partner program updates. “The OmniAb t...

May 10, 2024 | Company results

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies

The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...

May 01, 2024 | News

GE HealthCare Gains FDA 510(k) Clearance for Advanced Portrait VSM Vital Signs Monitor

GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor...

April 30, 2024 | News

Aptamer Group Ships Innovative Optimer Delivery Vehicle for Liver Disease Treatment

Optimer delivery vehicle has been shipped to a pharma partner for external evaluation The specific delivery vehicle could generate new precision t...

April 22, 2024 | News

Stay Connected